CompaniesLineagen

Lineagen

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

1

As Collaborator

1

Total Enrollment

217

By Phase

NA: 2

By Status

WITHDRAWN: 1COMPLETED: 1

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2013

2014

2015

2016

2017

Today

Hover over trial bars to see details

Recent Trials

NCT02420925Lead Sponsor

Effect of Celiac Plexus Block on Gastric Emptying and Symptoms Caused by Gastroparesis

Started: Oct 31, 2014 · Completed: Jun 30, 2016

NCT02414438Collaborator

Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study

217 participants

Started: Aug 31, 2014 · Completed: Jan 31, 2015

Funding History (10)

D

Jan 26, 2015

D

Nov 25, 2013

D/A

Apr 25, 2013

D/A

Apr 5, 2013

D/A

Apr 5, 2013

D

Mar 1, 2013

D/A

Jun 1, 2012

D

Jul 12, 2011

D

Jun 23, 2010

D

Jun 22, 2010

Related Companies

Bionano Genomics

acquired